Skip to content

Medical emergency? What to do

Chronic inflammation can help nurture skin cancer, study shows

3-RXPublished October 21, 20084 min read

Key points

  • Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, researchers have found.
  • "Inflammation should really help prevent a tumor," says Dr.
  • IDO quickly became part of the mix, creating a "suppressive" immune response that helped resulting precancerous cells grow into tumors, according to research published online in Proceedings of the National Academy of Sciences.
  • "We have long suspected that IDO is a component of certain kinds of inflammation that create suppression," says Dr.

Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, researchers have found.

IDO, an enzyme that works like a firefighter to keep inflammation under control, can be commandeered to protect early malignant cells, say Medical College of Georgia researchers studying an animal model of chronic inflammation and skin cancer.

"Inflammation should really help prevent a tumor," says Dr. Andrew Mellor, director of the MCG Immunotherapy Center and Georgia Research Alliance Eminent Scholar in Molecular Immunogenetics. In fact, there is strong evidence that inflammation triggers the immune response. "You want a good immune response; this is what protects you from pathogens," he says. "In this case, it's an unfortunate exploitation by malignant cells."

In a study with Drs. George C. Prendergast and Alexander J. Muller at the Lankenau Institute of Medical Research in Philadelphia, researchers gave mice a single dose of a carcinogen at the same time they began painting a tiny portion of skin with a poison ivy derivative twice weekly for 20 weeks.

IDO quickly became part of the mix, creating a "suppressive" immune response that helped resulting precancerous cells grow into tumors, according to research published online in Proceedings of the National Academy of Sciences. When they used the same protocol in a mouse in which IDO had been genetically deleted, tumor development dropped off dramatically.

The scenario is analogous to chronic sun exposure and skin cancer, says Dr. Mellor, the study's corresponding author. Ultraviolet radiation in sunlight causes malignant skin cells to appear but sun exposure also causes skin inflammation - evidenced by sunburn. The significance of the new study is that the researchers have shown that IDO, or indoleomine 2,3-dioxygenase, may be produced as a part of the inflammatory mix, which could then protect the malignant skin cells. "'Chronic' is the key word," Dr. Mellor says, noting high melanoma rates in Australians, for example, who live deep in the southern hemisphere.

"We have long suspected that IDO is a component of certain kinds of inflammation that create suppression," says Dr. Mellor. IDO's "firefighter" role probably resulted from the body's need to control inflammation in areas such as the gastrointestinal tract. The GI tract is constantly bombarded by food and microbes which could lead to debilitating and deadly inflammation.

"You really set a fire," Dr. Mellor says of inflammation. In fact, the English word inflammation comes from the Latin word inflamatio, which means to set a fire. But instead of helping protect healthy tissue as it does in the GI tract, IDO becomes problematic in cancer.

The latest finding shows IDO has a more important and earlier role than we thought in tumor formation, says Dr. Mellor. He and colleague Dr. David Munn led a research team that 10 years ago showed fetuses use IDO to avoid rejection by the mother's immune system. They and others have subsequently shown that tumors, including melanoma, as well as infectious agents such as HIV also use IDO to escape an immune attack. "IDO favors the tumor: The immune system basically sits back and watches the tumor grow," says Dr. Mellor.

Transplant patients, who require generalized immune inhibitors to keep their transplanted organs, also can be victims of this suppressive inflammation, says Dr. Mellor, noting their high risk of lymphoma after a few years of therapy.

The IDO inhibitor they have been using for years in the lab is now under study in breast cancer patients receiving chemotherapy. Drs. Mellor and Munn also have recruited Dr. Yukai He, cancer vaccine researcher, to MCG to work with them on how vaccines designed to direct an immune attack can work synergistically with the IDO inhibitor.

Toni Baker - 2008 October 21

Media Contacts

Toni Baker
706-721-4421
Schools of Graduate Studies and Medicine
Research and faculty news

Jennifer Hilliard
706-721-8604
School of Medicine
Research and faculty news

Amy Connell
706-721-8605
Student and Educational News

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.